130 related articles for article (PubMed ID: 8567032)
1. Impaired protein catabolism in Trypanosoma cruzi-infected macrophages: possible involvement in antigen presentation.
Plasman N; Guillet JG; Vray B
Immunology; 1995 Dec; 86(4):636-45. PubMed ID: 8567032
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
Prina E; Jouanne C; de Souza Lão S; Szabo A; Guillet JG; Antoine JC
J Immunol; 1993 Aug; 151(4):2050-61. PubMed ID: 8102156
[TBL] [Abstract][Full Text] [Related]
3. Relationship between granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and Trypanosoma cruzi infection of murine macrophages.
Olivares Fontt E; Vray B
Parasite Immunol; 1995 Mar; 17(3):135-41. PubMed ID: 7792097
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi upregulates nitric oxide release by IFN-gamma-preactivated macrophages, limiting cell infection independently of the respiratory burst.
Metz G; Carlier Y; Vray B
Parasite Immunol; 1993 Dec; 15(12):693-9. PubMed ID: 7877845
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
6. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.
Talvani A; Machado FS; Santana GC; Klein A; Barcelos L; Silva JS; Teixeira MM
Infect Immun; 2002 Aug; 70(8):4247-53. PubMed ID: 12117933
[TBL] [Abstract][Full Text] [Related]
9. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock.
Jacobs F; Dubois C; Carlier Y; Goldman M
Clin Exp Immunol; 1996 Feb; 103(2):233-8. PubMed ID: 8565305
[TBL] [Abstract][Full Text] [Related]
10. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A
Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma-activated immature macrophages exhibit a high Trypanosoma cruzi infection rate associated with a low production of both nitric oxide and tumor necrosis factor-alpha.
Plasman N; Metz G; Vray B
Parasitol Res; 1994; 80(7):554-8. PubMed ID: 7531849
[TBL] [Abstract][Full Text] [Related]
13. Activation of CD4+ and CD8+ parasite -specific T-cells by macrophages infected with live T. cruzi amastigotes.
Caulada-Benedetti Z; Vecchio LC; Pardi CC; Massironi SM; D'Império Lima MR; Abrahamsohn IA
Immunol Lett; 1998 Sep; 63(2):97-105. PubMed ID: 9761371
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.
Chaussabel D; Jacobs F; de Jonge J; de Veerman M; Carlier Y; Thielemans K; Goldman M; Vray B
Infect Immun; 1999 Apr; 67(4):1929-34. PubMed ID: 10085038
[TBL] [Abstract][Full Text] [Related]
15. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi affects nitric oxide production by murine peritoneal macrophages.
Pakianathan DR; Kuhn RE
J Parasitol; 1994 Jun; 80(3):432-7. PubMed ID: 8195945
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Shed By
Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
Front Immunol; 2018; 9():896. PubMed ID: 29755471
[TBL] [Abstract][Full Text] [Related]
19. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice.
Martins GA; Cardoso MA; Aliberti JC; Silva JS
Immunol Lett; 1998 Sep; 63(2):113-20. PubMed ID: 9761373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
